Skip to main content

Table 2 Baseline characteristics of the MACCE and MACCE-free groups

From: High triglyceride–glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention

Variable

MACCE group (n = 375)

MACCE-free group (n = 717)

P value

Age, years

64.5 ± 12.5

61.3 ± 12.4

< 0.001

Male

300 (80.0)

564 (78.7)

0.638

BMI, kg/m2

25.3 ± 2.1

25.1 ± 2.4

0.382

SBP, mmHg

128.7 ± 18.9

128.8 ± 22.7

0.939

DBP, mmHg

76.1 ± 13.9

78.0 ± 14.1

0.028

Heart rate, bpm

79.5 ± 15.4

79.7 ± 14.5

0.905

Killip class > 1

142 (37.9)

210 (29.3)

< 0.001

Smoker

199 (53.1)

317 (44.2)

0.012

Hypertension

261 (69.6)

417 (58.2)

< 0.001

Diabetes mellitus

117 (31.2)

153 (21.3)

< 0.001

Anemia

67 (17.9)

74 (10.3)

0.023

Previous AMI

9 (2.4)

15 (2.1)

0.447

Atrial fibrillation

15 (4.0)

33 (4.6)

0.385

Biochemical indicators

 NT-proBNP, pg/mL (IQR)

525.5 (31.0–2193.2)

546.8 (71.2–2603.2)

0.179

 Cardiac troponin I, ng/ml

13.1 (3.18–23.5)

12.7 (2.8–23.2)

0.480

 hs-CRP, mg/L (IQR)

7.6 (4.6–9.8)

7.1 (3.2–10.1)

0.152

 White blood cells, 109/L

10.4 ± 3.6

9.9 ± 3.4

0.046

 Neutrophil ratio

75.6 ± 12.8

75.8 ± 11.8

0.680

 Platelet, 109/L

217.2 ± 68.6

208.4 ± 56.8

0.024

 Albumin, g/L

36.4 ± 5.7

37.1 ± 4.5

0.021

 FPG, mmol/L

9.0 ± 4.2

8.3 ± 4.4

0.008

 Measured HbA1c, %

7.8 ± 1.3

7.3 ± 1.4

0.010

 TC, mmol/L

4.6 ± 1.4

4.6 ± 1.1

0.781

 Triglycerides, mmol/L

1.9 ± 1.6

1.9 ± 1.4

0.502

 HDL-C, mmol/L

1.1 ± 0.3

1.1 ± 0.2

0.417

 LDL-C, mmol/L

2.8 ± 0.9

2.9 ± 0.8

0.412

 Uric acid, umol/L

342.3 ± 112.2

321.6 ± 100.3

0.002

 eGFR, mL/min

79.4 ± 36.7

86.5 ± 37.4

0.008

Coronary angiography

 GPIIb/IIIa antagonists

121 (33.8)

237 (33.0)

0.515

 Anticoagulation

33 (8.8)

65 (9.1)

0.482

 Lesion vessels

3.3 ± 1.5

2.9 ± 1.5

< 0.001

 Three-vessel disease

213 (56.8)

348 (48.5)

< 0.001

 Number of stents

1.0 ± 0.49

1.12 ± 0.50

< 0.001

 Gensini score, (IQR)

73.1 (45.3–94.8)

67.0 (36.3–89.8)

0.035

Echocardiography

 LVEF

0.53 ± 0.12

0.55 ± 0.11

0.037

Medications use at discharge

 Aspirin

357 (95.2)

693 (96.7)

0.154

 Clopidogrel/Ticagrelor

369 (98.4)

708 (98.7)

0.414

 Statin

366 (97.6)

687 (95.8)

0.088

 Beta blockers

301 (80.3)

576 (80.3)

0.477

 ACEI/ARB

240 (64.0)

462 (64.4)

0.469

  1. Data are presented as the IQR, mean ± SD or n (%)
  2. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, AMI acute myocardial infarction, IQR interquartile range, hs-CRP hypersensitive C-reactive protein, FPG fasting plasma glucose, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, SCr serum creatinine concentration, eGFR estimated glomerular filtration rate, LVEF left ventricular ejection fraction, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker